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Abstract
The present study analyses the effect of dietary chia seed rich in n-3 a-linolenic acid on the mechanisms underlying dyslipidaemia and liver
steatosis developed in rats fed a sucrose-rich diet (SRD) for either 3 weeks or 5 months. The key hepatic enzyme activities such as fatty acid
synthase (FAS), acetyl-CoA carboxylase (ACC), glucose-6-phosphate dehydrogenase (G-6-PDH), carnitine palmitoyltransferase-1 (CPT-1)
and fatty acid oxidase (FAO) involved in lipid metabolism and the protein mass levels of sterol regulatory element-binding protein-1
(SREBP-1) and PPARa were studied. (1) For 3 weeks, Wistar rats were fed either a SRD with 11 % of maize oil (MO) as dietary fat or a
SRD in which chia seed replaced MO (SRD þ Chia). (2) A second group of rats were fed a SRD for 3 months. Afterwards, half the rats
continued with the SRD while for the other half, MO was replaced by chia for 2 months (SRD þ Chia). In a control group, maize
starch replaced sucrose. Liver TAG and the aforementioned parameters were analysed in all groups. The replacement of MO by chia in
the SRD prevented (3 weeks) or improved/normalised (5 months) increases in dyslipidaemia, liver TAG, FAS, ACC and G-6-PDH activities,
and increased FAO and CPT-1 activities. Protein levels of PPARa increased, and the increased mature form of SREBP-1 protein levels in
the SRD was normalised by chia in both protocols (1 and 2). The present study provides new data regarding some key mechanisms related
to the fate of hepatic fatty acid metabolism that seem to be involved in the effect of dietary chia seed in preventing and normalising/
improving dyslipidaemia and liver steatosis in an insulin-resistant rat model.
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In the last few years, it has been recognised that the dietary
intake of marine PUFA (fish oil rich in 20 : 5n-3 (EPA)
and 22 : 6n-3 (DHA)) appears to play a key role against the
adverse effects of the so-called metabolic syndrome, which
includes type 2 diabetes, insulin resistance (IR), dyslipidaemia,
hypertension, obesity and CVD(1–3), among other diseases.
Another nutritionally important n-3 PUFA is a-linolenic acid
(ALA, 18 : 3n-3). In human diets, the essential ALA is usually
derived from plant sources. Epidemiological and clinical
studies have suggested that a higher consumption of ALA
is associated with a reduced risk of CVD(4–6). Available
information indicates that dietary fats rich in ALA such as
linseed or perrilla oil, compared with those rich in linoleic
acid, decrease serum lipid concentrations in rats(7–9). One of
the richest botanical sources of ALA is the chia seed (Salvia
hispanica L.)(10,11). Chia, which is also rich in fibre and
minerals, was a major dietary component of the Mayans and
Aztecs. Chia seed has also received increasing attention for
its potential role in the prevention of dyslipidaemia. In this
regard, some animal studies have shown a reduction in
plasma TAG, NEFA and total cholesterol and an increase in
HDL-cholesterol when this food ingredient was used as a
source of dietary fat in normal or dyslipidaemic rats(12,13).
On the other hand, normal rats fed a sucrose-rich diet (SRD)
developed dyslipidaemia and IR among other biochemical
and metabolic alterations that mimic many aforementioned
signs of the metabolic syndrome(3,14,15). We have recently
demonstrated that feeding these rats for 3 weeks with a SRD
in which chia seed was the source of dietary fat prevents
the onset of dyslipidaemia and IR without changes in
plasma glucose levels. Moreover, dyslipidaemia and IR in
rats fed the SRD for a long term (5 months) were reversed
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without changes in plasma insulin levels when chia seed
instead of maize oil became the dietary source of fat for the
last 2 months of the feeding period(13). In addition, dietary
chia seed reduced increased epididymal and retroperitoneal
fat pad weights present in long-term SRD-fed rats(13), and
induced lipid redistribution and attenuated metabolic cardio-
vascular and hepatic signs of rats fed a high-carbohydrate–
fat diet(16). Ghafoorunissa et al.(9) showed that in weanling
normal rats fed a SRD, the partial substitution of dietary
linoleic acid with ALA for 3 months resulted in lowered
blood lipid levels and partially corrected sucrose-induced IR.
At present, the mechanisms by which dietary chia seed
could normalise or improve altered plasma lipid levels are
still not completely understood. It is possible that the pro-
portion of ALA (64 % of total lipids) in the chia seed as a
precursor of EPA and DHA, similar to the effect of fish oil,
could modify fatty acid metabolism in the liver through the
activation of PPARa and the down-regulation of sterol regu-
latory element-binding protein-1c (SREBP-1c), leading to a
decrease in serum lipids.
Therefore, the aim of the present study was to determine
whether changes in the fate of hepatic fatty acid metabolism
(lipogenesis–oxidation) could play a role in the mechanisms
underlying the effect of the dietary intake of chia seed in
the prevention/reversion of liver steatosis and dyslipidaemia
in rats fed a SRD. To achieve this goal, two experimental pro-
tocols were used. Both protocols were designed to investigate
the effectiveness of chia seed as a dietary source of fat in
SRD-fed rats in either: (1) preventing the development of the
aforementioned metabolic abnormalities or (2) improving/
reversing them in the presence of stable dyslipidaemia
achieved after long-term SRD feeding.
In both protocols, we measured the activities of the
following hepatic key enzymes involved in de novo lipogen-
esis and fatty acid oxidation: acetyl-CoA carboxylase (ACC);
fatty acid synthase (FAS); glucose-6-phosphate dehydrogenase
(G-6-PDH); carnitine palmitoyltransferase-1 (CPT-1 – the rate-
limiting enzyme for mitochondrial b-fatty acid oxidation); fatty
acid oxidase (FAO – generally used to monitor the activity of
PPARa). Furthermore, in the liver, we analysed the protein
mass levels of the transcription factors SREBP-1, which has
a central role in the induction of the gene expression of
lipogenic enzymes, and PPARa, which belongs to the super-
family of ligand-activated nuclear hormone receptors and
regulates the expression of fatty acid oxidation enzymes.
Materials and methods
Animals
Male Wistar rats initially weighing 180–190 g and purchased
from the National Institute of Pharmacology were maintained
with unrestricted access to water and food under controlled
temperature (22 ^ 18C), humidity and air flow conditions,
with a fixed 12 h light–dark cycle (lights on from 07.00 to
19.00 hours). They were initially fed a standard non-purified
diet (Ralston Purina). After 1 week of acclimatisation, the
rats were randomly assigned to one of the two experimental
protocols described in the following sections. The experimen-
tal protocols were approved by the Human and Animal
Research Committee of the School of Biochemistry, University
of Litoral, Argentina.
Dietary manipulations
Experimental protocol 1. A total of twenty-four rats were
randomised into three groups and fed an assigned diet
for 3 weeks (Table 1). The first group of rats received a
semi-synthetic diet containing maize starch (60 % energy),
protein (17 % energy) and maize oil as the source of fat
(23 % energy) (control diet; CD). The other two groups
received the same semi-synthetic diet with sucrose as the
carbohydrate and fat provided by maize oil (SRD) or by chia
seed (SRD þ Chia).
Experimental protocol 2. A total of forty rats were divided
into two groups and fed for 3 months with the CD (n 16) or
SRD (n 16) described previously in experimental protocol 1.
At that time, rats in the SRD group were randomly subdivided
into two subgroups. The first subgroup continued with the
SRD up to 5 months of feeding and the second subgroup
received the SRD þ Chia as the source of dietary fat for the
next 2 months. The control group was fed with the CD through-
out the experimental period. The fibre, vitamin mix and salt mix
contents of each diet were similar. The carbohydrate, protein
and fibre contents in the feed of the SRD þ Chia group were
balanced taking into account the amount of these nutrients
present in the chia seed. The fatty acid composition of the
chia seed was provided by the supplier (Table 2). The prep-
aration and handling of the diets have been reported else-
where(13). The food in the animal cages was shaded from light
and changed every day. All diets provided approximately
18·00 kJ/g of food. The weight of each animal and the energy
intake were recorded twice per week during the experimental
period in all groups and subgroups of rats.
At least six rats from the three dietary groups were used in
each procedure. They were anaesthetised with intraperitoneal
Table 1. Composition of the experimental diets* (based on the AIN-93
diet)
Diet ingredients (% energy) CD SRD SRD þ Chia
Carbohydrates
Starch 60 2·6 –
Sucrose – 57·4 57·4
Chia seed† – – 2·6
Fat
Maize oil 23 23 0·2
Chia seed – – 22·8
Protein
Casein (vitamin-free) 17 17 9·25
Chia seed – – 7·75
CD, control diet; SRD, sucrose-rich diet; SRD þ Chia, SRD þ chia seed.
* All diets contained by weight: salt mix, 3·5 % (AIN-93-MX(25)); vitamin mix,
1 % (AIN-93-VX(25)); choline chloride, 0·2 %; methionine, 0·3 %; fibre, 12 %. The
SRD þ Chia was balanced in the fibre and salt mix according to the amount of
each one in the chia seed provided by the manufacturer.
† Chia seed (Salba; Salvia hispanica L.): 362 g/kg diet. Chia composition (g/100 g
chia seed): carbohydrate, 37·45; insoluble fibre, 81 % of total carbohydrate; fat,
30·23; protein, 21·19. Mineral composition (mg/100 g chia seed): Na, 103·15; K,
826·15; Ca, 589·60; Fe, 11·90; Mg, 77·0; P, 604·0; Zn, 5·32; Cu, 1·66; Mn, 1·36.
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sodium pentobarbital (60 mg/kg body weight). Blood samples
were obtained from the jugular vein and rapidly centrifuged;
plasma was either immediately assayed or stored at 2208C.
Liver, epididymal, retroperitoneal and omental adipose tissue
were totally removed and weighed. Liver was immediately
frozen and stored at the temperature of liquid N2. Visceral
adiposity index (%) was calculated as follows and expressed
as adiposity percentage(16):
Visceral adiposity index ð%Þ ¼ ðretroperitoneal fat ðgÞ
þ omental fat ðgÞ þ epididymal fat ðgÞÞ=body weight ðgÞ
£ 100:
Analytical methods
Plasma TAG, NEFA and glucose levels were determined by
spectrophotometric methods and insulin by immunoreactive
assays as described previously(17). The insulin assays were
calibrated against rat insulin standard (Novo Nordisk). TAG
content was determined in the homogenate of frozen liver,
as described previously(18).
Enzymatic activity assays
ACC was assayed according to Zimmermann et al.(19).
The cytosolic fraction was obtained after centrifugation of
the supernatant at 30 000 rpm for 1 h at 48C. ACC was
measured by an NADH-linked assay. FAS activity was assayed
on the cytosolic fraction of liver tissue by measuring malonyl
CoA-dependent oxidation of NADPH at 378C, as described
previously(18). Liver tissue G-6-PDH, peroxisomal FAO and
CPT-1 were determined as described recently(18).
Western blot analysis of liver protein mass levels of PPARa
and sterol regulatory element-binding protein-1
Liver homogenates were prepared for PPARa protein mass level
analysis and Western blots were run under reduced–denatured
protein (Laemmli buffer) as described by Hein et al.(18). Kidney
tissue extracts were employed as PPARa positive control.
Nuclear and microsomal membrane extracts of SREBP-1
from the liver of rats were obtained by centrifugation in a
sucrose gradient as described by Ascencio et al.(20) with slight
modifications. Tissue was homogenised in lysis buffer (0·5 g
tissue/3·75 ml) containing 0·3 M-sucrose, 5 mM-dithiothreitol,
5 mM-MgCl2, 0·05 % Triton X-100, 10 mM-Tris–HCl (pH 7·5)
and tissue protease inhibitor cocktail (5ml/100 mg). Tissue
homogenates were centrifuged at 2000 rpm for 10 min at 48C.
The supernatant was used as the microsomal membrane extract.
The pellet was resuspended in 2 ml of sucrose buffer containing
2·3 M-sucrose, 2 mM-MgCl2, 10 mM-Tris–HCl (pH 7·5) and tissue
protease inhibitor cocktail (5ml/100 mg). The suspension was
centrifuged at 32 000 rpm for 60 min at 48C. The pellet was
used as the nuclear extract and resuspended in 600ml of storage
buffer containing 50 % glycerol, 2 mM-MgCl2, 0·1 mM-EDTA and
50 mM-HEPES (pH 7·5). The extracts were stored at 2708C.
The protein concentration of the extracts was determined
by the Bradford assay. Protein samples were resolved on
SDS–PAGE according to Laemmli. Before electrophoresis,
all samples were boiled for 2 min in the presence of 1 % SDS
with 200mM-dithiothreitol. For immunoblotting, proteins in
the SDS–PAGE gel were transferred to polyvinyldifluoride
membranes. The membranes were probed with specific anti-
bodies (rabbit anti-PPARa antibody and rabbit anti-SREBP-1
antibody; Santa Cruz Biotechnology, Inc.), respectively. The
blots were then incubated with horseradish peroxidase-linked
secondary antibody followed by chemiluminescence detection
according to the manufacturer’s instructions (Super Signal
West Pico chemiluminescence detection; Pierce Biotechno-
logy). b-Actin was used as a loading control. The intensity of
bands was quantified by National Institutes of Health imaging
software (http://rsb.info.nih.gov/nih-image/). The relation-
ship between the amount of samples subjected to immuno-
blotting and the signal intensity observed was linear under
the aforementioned conditions. In addition, the liver SREBP-1
analysis showed one electrophoretic band with an approximate
molecular weight of 125 kDa and another band of 68 kDa;
these bands represent the precursor and mature forms of
SREBP-1, respectively(21).
Statistical analysis
Sample sizes were calculated on the basis of measurements
previously made with rats fed either a CD or a SRD(15,17,18),
considering an 80 % power. Results are expressed as means
with their standard errors. Statistical comparisons were done
transversely between the different dietary groups. Statistical
significance between the groups was determined by one-
way ANOVA, with one factor (diet) followed by the inspection
of all differences between pairs of means by the Newman–
Keuls test(22). Differences having P values lower than 0·05
were considered to be statistically significant (SPSS 15.0 for
Windows; SPSS, Inc.).
Results
Body weight gain, energy intake, visceral adiposity index,
plasma metabolite levels and liver TAG contents
Body weight and energy intake were carefully monitored in
all groups of rats throughout both experimental periods.
As shown in Table 3, after 3 weeks on the diet (experimental
Table 2. Maize oil and chia seed fatty acid composition (g/100 total
fatty acids)
Fatty acids* Maize oil Chia seed†
16 : 0 10·40 6·60
18 : 0 2·60 2·80
18 : 1n-9 32·10 6·80
18 : 2n-6 51·50 18·60
18 : 3n-3 0·76 64·60
20 : 1n-9 0·45 0·30
Total saturated 13·40 12·04
Monounsaturated 32·55 7·44
Polyunsaturated
n-6 51·50 18·60
n-3 0·76 64·60
n-6:n-3 67·80 0·287
* Minor components made content up to 100 %.
† Salba; Salvia hispanica L. (Agrisalba SA, Buenos Aires, Argentina).
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protocol 1), body weight and energy intake did not differ
between the groups. The visceral adiposity index was similar
in the three dietary groups. The values were as follows
(six animals per group): 2·51 (SEM 0·12) g in the CD group;
2·18 (SEM 0·10) g in the SRD group; 2·58 (SEM 0·08) g in the
SRDþChia group. As previously shown(13), a significant
increase in body weight and energy intake occurred in rats
fed a SRD from 3 to 5 months compared with those fed a
CD (Table 4, experimental protocol 2). However, in spite of
a similar energy intake recorded in both the SRD and SRD þ
Chia groups during the last 2 months of the experimental
period (3–5 months), weight gain at 5 months was slightly
lower in the latter group. Moreover, the SRD-fed rats
showed a significant increase in retroperitoneal, omental and
epididymal fat pad weights, and therefore the visceral adi-
posity index was significantly higher compared with both
CD and SRD þ Chia groups. Chia seed as a dietary source of
fat in the SRD significantly reduced the weight of the afore-
mentioned fat tissues, reaching values similar to those
recorded in the CD-fed group. The visceral adiposity index
was as follows (six animals per group): 3·73 (SEM 0·10) in the
CD group; 6·23 (SEM 0·70) in the SRD group; 4·09 (SEM 0·21) in
the SRD þ Chia group (P,0·05, SRD v. CD and SRD þ Chia).
At the end of 3 weeks on the diet (experimental protocol 1),
both plasma TAG and NEFA levels were significantly higher in
SRD-fed rats compared with CD-fed rats. The presence of chia
seed as the principal dietary source of fat in the SRD group
prevented the increase in these parameters. No changes in
plasma glucose were recorded in the three dietary groups.
Moreover, confirming previous reports(13), hyperinsulinaemia
was present in SRD-fed rats. When chia seed replaced maize
oil in the SRD, insulin levels were not statistically different
from the CD- or SRD-fed animals (Table 3). In agreement
with previous publications(13,23), plasma TAG, NEFA and
glucose levels were higher in rats fed the SRD for 5 months
compared with the age-matched control fed the CD
(Table 4). Similar values were observed in rats fed the SRD
for 3 months (data not shown). All the variables returned to
control values in SRD-fed rats in which chia seed replaced
maize oil for the last 2 months of the feeding period (exper-
imental protocol 2). No statistically significant differences in
plasma insulin levels were observed at the end of the exper-
imental period between the three dietary groups (Table 4).
Chia seed prevented the enhanced liver TAG content
recorded in rats fed the SRD for 3 weeks. Furthermore, the
replacement of maize oil by chia seed in the SRD for the last
2 months of the experimental period (5 months) significantly
lowered the liver TAG content, although the values were still
higher than those observed in CD-fed rats (Tables 3 and 4).
Hepatic enzyme activities involved in lipid metabolism
As shown in Table 5, the liver of SRD-fed rats, compared with
that of CD-fed rats, showed an enhancement of ACC, FAS and
G-6-PDH activities (key enzymes related to de novo fatty acid
synthesis) either after 3 weeks or 5 months on the diet.
However, the substitution of maize oil by chia seed as dietary
fat in the SRD for 3 weeks was able to prevent these altera-
tions. Furthermore, the activity of G-6-PDH decreased signifi-
cantly, reaching values below those of the CD group. Besides,
a significant reduction in ACC, FAS and G-6-PDH activities
(which returned to values similar to those recorded in CD-
fed rats) was observed in the liver of SRD-fed rats when
chia seed replaced maize oil for the last 2 months of the
feeding period (Table 5).
On the other hand, Table 6 shows the hepatic activities of
key enzymes related to mitochondrial (CPT-1) and peroxiso-
mal (FAO) fatty acid oxidation in the three dietary groups.
Table 3. Body weight, energy intake, plasma metabolite levels and TAG liver of rats fed the control
diet (CD), the sucrose-rich diet (SRD) or the SRD þ chia seed (SRD þ Chia)‡
(Mean values with their standard errors)
Experimental protocol 1 (3 weeks)
CD SRD SRD þ Chia
Mean SEM Mean SEM Mean SEM
Body weight (g)§
Initial 189·0 2·7 190·3 3·1 185·2 3·6
Final 275·3 5·3 277·6 4·3 276·0 2·5
Energy intake (kJ/d)
0–3 weeks 290·0 18·0 312·0 23·0 309·0 17·0
Plasmak
TAG (mM) 0·68 0·05 1·52*** 0·13 0·60 0·03
NEFA (mM) 252·0 17·0 595·0*** 24·0 245·0 14·0
Glucose (mM) 6·7 0·2 6·8 0·3 7·3 0·5
Insulin (pM) 416·7 25·0 584·8† 42·6 548·6 61·8
Liverk
TAG (mmol/g wet weight) 9·9 0·5 18·1*** 1·2 10·1 0·6
***Mean values were significantly different from those of the CD and SRD þ Chia groups (P,0·001).
† Mean value was significantly different from that of the CD group (P,0·05).
‡ For details of procedures and diets, see the Materials and methods section and Table 1.
§ n 24.
kn 6.
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Chia seed as a source of dietary fat was able to prevent the
decreased activity of CPT-1 observed in rats fed the SRD
for 3 weeks, while FAO activity significantly increased
(P,0·05), reaching values above those recorded in the CD
and SRD groups. Similarly, the presence of chia seed as dietary
fat reverted the decreased CPT-1 activity recorded in rats fed
the SRD for 5 months, reaching values above those observed
in age-matched controls fed the CD. Moreover, FAO activity
was also significantly increased in the SRD þ Chia group.
Interestingly, compared with the CD-fed group, no changes
in FAO activity were observed in rats fed the SRD either for
a short term (3 weeks) or 5 months in which maize oil was
the source of dietary fat (Table 6).
Liver sterol regulatory element-binding protein-1 protein
mass levels in the membrane fraction (precursor form)
and nuclear extracts (mature form)
To examine whether or not chia seed feeding could alter the
SREBP-1 protein mass, the precursor and mature forms of
SREBP-1 protein mass levels in the liver of SRD- and SRD þ
Chia-fed rats were measured by immunoblotting. Since the
antibody of SREBP-1 reacted with both SREBP-1a and
SREBP-1c forms, we could not distinguish these two forms
and thus used the non-committal term SREBP-1 (in the
mouse liver, the ratio of SREBP-1c:1a transcriptors was
9:1(21)). The 125 and 68 kDa proteins observed represent the
Table 4. Body weight, energy intake, plasma metabolite levels and TAG liver of rats fed the control
diet (CD), the sucrose-rich diet (SRD) or the SRD þ chia seed (SRD þ Chia)‡
(Mean values with their standard errors)
Experimental protocol 2 (5 months)
CD SRD SRD þ Chia
Mean SEM Mean SEM Mean SEM
Body weight (g)§
Initial 184·3 2·9 185·3 4·4 183·4 3·2
3 months 362·4 5·1 375·5 4·2 371·3 5·8
Final 430·0 7·1 490·2††† 8·1 475·1†† 10·0
Energy intake (kJ/d)
0–3 months 288·4 12·5 295·3 9·3 291·2 10·5
3–5 months 289·0 10·0 355·0††† 6·0 348·0†† 12·0
Plasmak
TAG (mM) 0·70 0·07 1·85*** 0·12 0·65 0·07
NEFA (mM) 305·0 13·0 735·0*** 36·0 339·0 18·0
Glucose (mM) 6·9 0·1 8·3*** 0·2 7·2 0·2
Insulin (pM) 504·2 33·3 526·4† 43·7 625·0 63·2
Liverk
TAG (mmol/g wet weight) 12·1 0·9 25·2*** 1·3 16·8†† 1·1
Mean values were significantly different from those of the CD and SRD þ Chia groups: ***P,0·001.
Mean values were significantly different from those of the CD group: ††P,0·01, †††P,0·001.
‡ For details of procedures and diets, see the Materials and methods section and Table 1.
§ n 40.
kn 6.
Table 5. Acetyl-CoA carboxylase (ACC), fatty acid synthase (FAS) and glucose-6-phosphate dehydrogenase
(G-6-PDH) activities in the liver of rats fed the control diet (CD), the sucrose-rich diet (SRD) or the SRD þ chia seed
(SRD þ Chia)‡
(Mean values with their standard errors; n 6 per group)
ACC (pkatal/mg
protein)
FAS (pkatal/mg
protein)
G-6-PDH
(pkatal/mg
protein)
Diets Time of diet Mean SEM Mean SEM Mean SEM
Experimental protocol 1
CD 3 weeks 591·2 28·4 182·0 20·1 389·1 8·3
SRD 3 weeks 818·3* 41·7 305·6*** 11·7 477·6** 18·4
SRD þ Chia 3 weeks 656·3 40·1 217·1 5·0 235·5†† 6·7
Experimental protocol 2
CD 5 months 731·5 41·7 118·6 3·3 329·0 33·4
SRD 5 months 1543·1*** 36·8 217·1*** 6·7 465·9*** 31·7
SRD þ Chia 5 months 699·7 123·6 131·9 5·0 309·0 20·0
Mean values were significantly different from those of the CD and SRD þ Chia groups: *P,0·05, **P,0·01, ***P,0·001.
Mean value was significantly different from that of the CD group: ††P,0·01.
‡ For details of procedures and diets, see the Materials and methods section and Table 1.
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precursor and mature forms of SREBP-1. Each gel contained
an equal number of samples from the CD, SRD and SRD
þChia groups (Fig. 1(a) and (b)). After densitometry of immu-
noblots, the precursor and mature forms of SREBP-1 of the
CD group were normalised to 100 % and both SRD and SRD
þChia were expressed relative to this. The quantitative and
qualitative analysis of Western blots showed no changes in
the relative abundance of the precursor form of SREBP-1
in the three dietary groups either after 3 weeks or 5 months
on the SRD compared with CD-fed rats (Fig. 1(a), experimen-
tal protocols 1 and 2). However, the relative abundance of the
mature form of the SREBP-1 protein was significantly
increased (P,0·05) in SRD-fed rats either after 3 weeks or
5 months on the diet (Fig. 1(b), experimental protocols 1
and 2). The substitution of maize oil by chia seed in the
SRD for 3 weeks prevented the increase in the mature form
of SREBP-1 protein mass levels (values were similar to those
of the CD group), and when chia seed replaced maize oil
for the last 2 months in rats fed the SRD for 5 months, the rela-
tive abundance of the mature form of SREBP-1 protein mass
levels returned to the control values (Fig. 1(b), experimental
protocols 1 and 2). The ratios of mature:precursor relative pro-
tein levels of SREBP-1 (six animals per group) after the 3-week
feeding period were 1·35 (SEM 0·11) in the SRD group v. 0·94
(SEM 0·05) in the SRDþChia group (P,0·01), and after 5
months on the diet 1·21 (SEM 0·04) in the SRD group v. 0·93
(SEM 0·08) in the SRDþChia group (P,0·01).
Protein mass levels of PPARa
Since the activities of CPT-1 and FAO were modified in
the liver of both SRD and SRD þ Chia groups either after
3 weeks or 5 months on the diet, we examined the protein
mass levels of the nuclear receptor PPARa. The immunoblot-
ting of liver tissue revealed a single 55 kDa band consistent
with PPARa. Each gel contained an equal number of samples
from the CD, SRD and SRD þ Chia groups (Fig. 2). After den-
sitometry of immunoblots, PPARa of the CD group was nor-
malised to 100 % and both SRD and SRD þ Chia were
expressed relative to this. The quantitative and qualitative
abundance of Western blot showed that the relative abun-
dance of PPARa protein levels significantly decreased
(P,0·05) in the liver of the SRD group either after 3 weeks
or 5 months on the diet compared with rats fed the CD
(Fig. 2). The replacement of maize oil by chia seed as the diet-
ary source of fat was able to prevent the decrease in PPARa
protein levels (3 weeks) in SRD-fed rats or even significantly
increased (P,0·05) in rats fed the SRD for 5 months (Fig. 2),
reaching values above those of the CD group (P,0·05, SRD þ
Chia v. CD).
Discussion
Extending our previous research, the present study provides
new information concerning some of the possible underlying
mechanisms sustaining the beneficial effects of chia seed
as a dietary source of fat in the prevention, improvement
and/or reversal of dyslipidaemia and liver steatosis that devel-
oped in rats rendering dyslipidaemic and insulin resistant
by feeding them with a SRD.
The major new findings arising from these investigations
are as follows. (1) Dietary chia seed simultaneously adminis-
tered with a SRD for 3 weeks (experimental protocol 1) pre-
vented the onset of dyslipidaemia and the increase in liver
TAG storage (liver steatosis) present in SRD-fed rats by signifi-
cantly decreasing both the protein mass levels of the mature
form of SREBP-1 (without changes in the protein mass level
of the precursor form) and the activities of key enzymes
(ACC, FAS and G-6-PDH) involved in hepatic de novo lipogen-
esis, reaching values that did not differ from those observed in
the control group fed a CD. In addition, dietary chia seed was
able to normalise the low protein mass levels of PPARa and
the activity of the enzyme (CPT-1) involved in mitochondrial
fatty acid oxidation; at the same time, it significantly increased
the FAO activity involved in peroxisomal fatty acid oxidation,
reaching values above those recorded in the CD-fed group. (2)
The significant increase in both the protein mass levels of the
mature form of SREBP-1 and the enzymatic activities of hepa-
tic ACC, FAS and G-6-PDH observed in rats fed a SRD for 5
months were completely normalised by shifting the source
of fat in the SRD from maize oil to chia seed for the last 2
months of the experimental period (experimental protocol
2). Under these experimental conditions, chia seed increased
both the low CPT-1 and FAO activities by 1·5- and 2-fold
above the value observed in the CD-fed group, respectively.
Moreover, dietary chia seed increased the protein mass
levels of PPARa, reaching values significantly higher than
those recorded in the CD group. This was accompanied by
a significant reduction in hepatic TAG content, the visceral
adiposity index without significant changes in energy intake
and total body weight and, as previously shown, a normali-
sation of dyslipidaemia and plasma glucose levels despite
the fact that there were no changes in insulinaemia.
Table 6. Carnitine palmitoyltransferase-1 (CPT-1) and fatty acid oxi-
dase (FAO) activities in the liver of rats fed the control diet (CD),
the sucrose-rich diet (SRD) or the SRD þ chia seed (SRD þ Chia)§
(Mean values with their standard errors; n 6 per group)
CPT-1
(pkatal/mg
protein)
FAO
(pkatal/mg
protein)
Diets Time of diet Mean SEM Mean SEM
Experimental protocol 1
CD 3 weeks 32·9 3·3 48·0 4·5
SRD 3 weeks 17·2* 2·2 44·8 4·6
SRD þ Chia 3 weeks 31·6 4·1 68·5‡ 7·6
Experimental protocol 2
CD 5 months 18·9 2·2 28·0 1·7
SRD 5 months 11·7** 1·7 27·3 2·3
SRD þ Chia 5 months 28·4†† 1·8 51·8‡ 4·8
Mean values were significantly different from those of the CD and SRD þ Chia
groups: *P,0·05, **P,0·01.
Mean value was significantly different from that of the CD group: ††P,0·01.
Mean values were significantly different from those of the CD and SRD groups:
‡P,0·05.
§ For details of procedures and diets, see the Materials and methods section and
Table 1.
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Different studies including ours have demonstrated that
in rats fed a high-sucrose or high-fructose diet for a short
(3–5 weeks) or long (4–8 months) period, a combination
of increased VLDL-TAG secretion and a defective removal
mechanism of TAG from the circulation lead to a substantial
hypertriacylglycerolaemia. This was accompanied by a
significant increase in TAG storage within the liver
tissue(3,24). The main transcription factor controlling lipid syn-
thesis in the liver is SREBP-1. Several pieces of evidence
suggested that the SREBP-1c isoform has a central role in
the induction of the gene expression of a number of lipogenic
enzymes including ACC and FAS, among others(25,26). In this
regard, hepatic gene expression of SREBP-1, protein mass
levels and the gene expression and activities of lipogenic
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Fig. 1. Liver protein mass levels of (a) the precursor and (b) mature forms of sterol regulatory element-binding protein-1 (SREBP-1) of rats fed a control diet
(CD, ), a sucrose-rich diet (SRD, ) or a SRD þ chia seed (SRD þ Chia, ). (a) Experimental protocols 1 and 2. Top: a representative immunoblot of the liver
precursor form of SREBP-1 from the CD-, SRD- and SRD þ Chia-fed rats. Molecular marker is shown on the right. Lane 1, CD; lane 2, SRD; lane 3, SRD þ Chia.
Bottom: Densitometric immunoblot analysis of the precursor form of SREBP-1 protein mass levels in liver tissue of rats fed a CD, SRD or SRD þ Chia.
(b) Experimental protocols 1 and 2. Top: a representative immunoblot of the liver mature form of SREBP-1 from the CD-, SRD- and SRD þ Chia-fed rats.
Molecular marker is shown on the right. Lane 1, CD; lane 2, SRD; lane 3, SRD þ Chia. Bottom: Densitometric immunoblot analysis of the mature form of
SREBP-1 protein mass levels in the liver tissue of rats fed a CD, SRD or SRD þ Chia. Values are means (six animals per group), with their standard errors
represented by vertical bars, and expressed as a percentage relative to each CD, respectively. * Mean values were significantly different from those of the CD
and SRD þ Chia groups (P,0·05).
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enzymes were increased in a high-sucrose/fructose diet(18,27).
In contrast, the mRNA contents and protein mass levels of
PPARa as well as the gene expression and activities of key
enzymes of fatty acid oxidation were significantly decreased
in rats given a sucrose/fructose-rich diet for different lengths
of time (2–8 months)(18,27).
The present results are in agreement with the aforemen-
tioned studies showing that both hepatic lipogenic and oxi-
dative mitochondrial fatty acid oxidation enzyme activities
are coordinately increased and decreased, and this was
accompanied by a parallel increase and decrease in the pro-
tein mass levels of SREBP-1 and PPARa, respectively. This
suggests that sucrose induces a shift in the metabolic fate of
lipid – synthesis v. oxidation – which could be one of the
mechanisms involved in increased TAG storage within the
liver cells leading to hepatic steatosis in rats fed a SRD. Inter-
estingly, all these changes were expressed not only after long-
term SRD feeding but early after 3 weeks on the diet.
On the other hand, it has been shown that n-3 PUFA (e.g.
EPA, DHA) in vivo or in cell culture inhibited the transcription
of gene encoding for key lipogenic enzymes such as ACC,
FAS, SCD-1, among others(1,25,28,29). Increases in cellular n-3
EPA have also resulted from ingestion of vegetable sources
rich in ALA such as flaxseed and perrilla oils and chia
seed(8,13,30). ALA could be converted to long-chain n-3 PUFA
(mainly EPA) and to a lesser extent to DHA in the liver. It is
well known that both the absolute amount of ALA and the
ratio LA:ALA influence the ALA conversion to EPA as a result
of the known competition between n-6 and n-3 fatty acids
for desaturation since LA reduces D-6 desaturase(31). The
ratio of LA:ALA in the SRD þ Chia group was 0·287 v. 67·8
in the SRD group (maize oil as dietary fat), and Jeffery
et al.(32) recorded that the maximum hypertriacylglycerolae-
mic and hypercholesterolaemic effects were obtained at a
LA:ALA ratio of 0·33. To the best of our knowledge, the pre-
sent study is the first one to demonstrate that in dyslipidaemic,
insulin-resistant SRD-fed rats, the higher amount of ALA in
the dietary chia seed, or their metabolites EPA and, to a
minor extent, DHA, opposite to LA, prevents the increase in
both the hepatic lipogenic enzyme activities of ACC, FAS
and G-6-PDH and the mature form of SREBP-1 protein mass
levels. Moreover, when chia seed replaced maize oil for the
last 2 months of the 5-month SRD feeding period, the
normalisation of hepatic ACC, FAS and G-6-PDH activities
was accompanied by the decrease in the mature form of
SREBP-1 protein mass levels. Interestingly, either under the
3-week or 5-month feeding period, the precursor form of
SREBP-1 protein mass levels remained unchanged. Therefore,
the ratio of mature:precursor relative protein levels that
increased in SRD-fed rats returned to normal in the SRD
þChia group. In addition, the concomitant administration
of dietary chia seed for 3 weeks enhanced the activity of
FAO, contributing to the prevention of the increases in hepatic
TAG content by increased peroxisomal fatty acid oxidation.
It also prevents the decreased activity of CPT-1 observed in
SRD-fed rats, without significant changes in the protein mass
levels of PPARa. The latter was an unexpected finding since
FAO enzymatic activity is generally used to monitor the
activity of PPARa(18). However, Neschen et al.(33) showed a
significant increase in hepatic peroxisome and both FAO
mRNA and 3 ketoacyl-CoA mRNA without changes in the
expression of PPARa and CPT-1 in rats fed for 3 weeks a
high-fat diet containing 59 % of fat-derived energy as fish oil.
On the other hand, increased PPARa protein levels and
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Fig. 2. Liver protein mass levels of PPARa of rats fed a control diet (CD, ),
a sucrose-rich diet (SRD, ) or a SRD þ chia seed (SRD þ Chia, ). Exper-
imental protocols 1 and 2. Top: a representative immunoblot of liver PPARa
from the CD-, SRD- and SRD þ Chia-fed rats. Molecular marker is shown on
the right. Lane 1, kidney tissue as a positive control; lane 2, CD; lane 3,
SRD; lane 4, SRD þ Chia. Bottom. Densitometric immunoblot analysis of
PPARa protein mass levels in the liver tissue of rats fed a CD, SRD or
SRD þ Chia. Values are means (six animals per group), with their standard
errors represented by vertical bars, and expressed as a percentage relative
to the CD. * Mean values were significantly different from those of the CD
and SRD þ Chia groups (P,0·05). †† Mean values were significantly differ-
ent from those of the CD group (P,0·01).
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higher activities of the key enzymes of mitochondrial (CPT-1)
and peroxisomal (FAO) fatty acid oxidation were recorded
when chia seed replaced maize oil for the last 2 months
of the 5-month SRD feeding period. These results clearly
suggest that the opposite hepatic changes induced by dietary
chia seed in the activities of key enzymes involved in lipogen-
esis and fatty acid oxidation, accompanied by similar changes
in the protein mass levels of mature SREBP-1 and PPARa,
could be involved in the mechanisms leading to a reduction
in liver TAG synthesis, normalising/improving liver steatosis
and dyslipidaemia (TAG and NEFA reached control values) in
rats fed a SRD. Interestingly, Poudyal et al.(16) recently demon-
strated a decrease in hepatic steatosis and reduced fibrosis and
inflammation in the histological analysis of the liver of
rats fed a high-carbohydrate–high-fat diet supplemented with
5 % of chia seed for 8 weeks. Since ALA is metabolised to EPA
and DHA, it is also possible that these metabolites rather
than ALA per se could induce the aforementioned changes.
In this regard, in mice fed a high-carbohydrate–fat-free diet,
Yahagi et al.(25) showed that EPA ethyl ester-specific suppres-
sion of liver lipogenic enzymes is mediated by the reduction
of mature SREBP-1c protein. Moreover, in B57BL/6J mice,
Nakatani et al.(21) showed that low fish oil – rich in EPA and
DHA – feeding inhibits the SREBP-1 proteolytic cascade,
while a high increase in fish oil decreases mRNA SREBP-1
levels in the liver. Kim(30) showed a reduction in the activities
of FAS, G-6-PDH and malic enzyme and mRNA FAS expression
in the liver of rats fed perrilla oil compared with those fed
beef tallow, while Ide et al.(34,35) showed that normal rats
fed 15 % of perrilla oil for 15 d significantly increased the
mRNA levels and activities of CPT-1 and FAO compared with
those of age-matched controls fed safflower oil.
In addition to the prevention and/or normalisation of dys-
lipidaemia and the increase in liver TAG content, dietary
chia seed was able to normalise plasma glucose levels without
changes in insulinaemia in rats fed the SRD for a long time
(5 months). Moreover, the whole-body peripheral IR present
in rats fed a SRD was prevented (3 weeks) or completely
normalised (5 months) under chia seed administration(13).
This effect could also be related to the subsequent changes
in fatty acid content in membrane phospholipids of insulin
target tissues including liver tissue, due to the absolute and
relative amounts of LA and ALA in the diet and the competitive
interactions in the metabolism of LA and ALA to long-chain
n-6 and n-3 PUFA, which could in turn improve insulin sensi-
tivity. Interestingly, a high content of EPA and DHA was
observed in the hepatic membrane of rats fed perrilla oil,
although this oil contained neither EPA nor DHA(7). In this
regard, we have recently demonstrated a significant increase
in plasma ALA, EPA and DHA in rats fed a SRD when chia
seed replaced maize oil as the source of dietary fat(13).
On the other hand, the present results extend our previous
observations and show that the increased visceral adiposity
index recorded in long-term SRD-fed rats was significantly
reduced in the SRD þ Chia group, and this effect is not
related to energy differences. Okuno et al.(36) also observed
a reduction of fat pad in rats fed perrilla oil compared with
those fed a saturate fat or LA-rich fat diet, and Poudyal
et al.(16) showed a reduction in the visceral adiposity index
due to a decrease in both retroperitoneal and omental but
not epididymal fat pad in rats fed a high-carbohydrate–high-
fat diet supplemented with 5 % of chia seed. Moreover, in
rats fed diets containing 0·095–6·3 % of ALA and constant
n-6 PUFA levels for 3 weeks, Muhlhausler et al.(37) have
recently shown that fat depots in different anatomical
locations have different degrees of responsiveness to altered
levels of n-3 and n-6 long-chain PUFA in the body.
In brief, the present study provides new data regarding
some key mechanisms related to the fate of hepatic fatty
acid metabolism (lipogenesis/oxidation) that could be invol-
ved in the effect of dietary chia seed in preventing, normali-
sing or improving dyslipidaemia, liver steatosis and altered
glucose homeostasis in a dyslipidaemic insulin-resistant rat
model. Finally, these results, although promising, warrant
further research before extrapolating the use of chia seed as
a complementary nutrient that could help in the treatment of
some signs of the metabolic syndrome in humans, especially
considering the few human studies published so far. Interest-
ingly, in healthy individuals receiving 0, 7·5, 15 or 25 g of Salba
(S. hispanica L.), baked into white bread, Vuksan et al.(38)
have recently shown a reduction in postprandial glucose
excursion and a prolongation of satiety independently of
the amount of Salba used. In addition, they have previously
shown a reduction in systolic blood pressure, coagulation
and inflammatory markers after 12 weeks of dietary Salba sup-
plement in well-controlled subjects with type 2 diabetes(39).
Muramatsu et al.(40) showed that a higher ALA intake was
significantly associated with a lower prevalence of IR in
middle-aged, normal-weight Japanese individuals, both male
and female.
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